EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Histopathological Assessment of Precision‐Cut Kidney Slices: A Live Human Tissue‐Based Model of Renal Fibrosis

Andreas Riishede, Camilla Merrild, Seulgi Hyun, Mia G Madsen, Anna K Keller, Henricus A M Mutsaers, Rikke Nørregaard iD, Lene N Nejsum iD

APMIS · 2026-06 · 134 (6)

DOI: 10.1111/apm.70226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APMIS, online erschienen am 29.05.2026. Verfasst von Andreas Riishede und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Hauptthemen laut MEDLINE: Kidney, Renal Insufficiency, Chronic. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation, Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is characterized by a progressive decline of renal function. A major challenge in CKD drug development is the low success rate of drug candidates, with fewer than 10% of drugs entering Phase I clinical trials demonstrating clinical benefit. Traditional in vitro and in vivo models, while valuable, do not fully recapitulate human kidney complexity. To address this, we utilized human precision‐cut kidney slices (PCKS), an ex vivo model that preserves human cellular diversity and organ architecture. Although this model lacks factors such as blood flow and osmotic gradients, it enables controlled induction of fibrosis through TGF‐β treatment. To assess potential therapeutic interventions, we adapted a histopathological scoring system that was originally developed for human kidney biopsies. Our findings demonstrate that PCKS exhibit progressive fibrosis and tubular atrophy during culture up to 48 h, with TGF‐β treatment further exacerbating these effects at the 48 h time‐point. In contrast to PCKS from healthy patients, 48 h incubation of PCKS from CKD patients did not induce additional fibrosis or tubular atrophy. Thus, our scoring system provides a robust method for assessing fibrosis and tubular atrophy in human PCKS and may serve as a promising tool in preclinical drug screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KidneyRenal Insufficiency, ChronicHumansFibrosisTransforming Growth Factor beta

Substanzen

Transforming Growth Factor beta

Autor:innen und Institutionen

  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Urology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.

ORCID-Profile: Rikke Nørregaard, Lene N Nejsum

Förderung

  • Novo Nordisk Foundation
  • Novo Nordisk Fonden

Zitieren

APA

Riishede, A., Merrild, C., Hyun, S., Madsen, M. G., Keller, A. K., Mutsaers, H. A. M., Nørregaard, R., & Nejsum, L. N. (2026). Histopathological Assessment of Precision‐Cut Kidney Slices: A Live Human Tissue‐Based Model of Renal Fibrosis. APMIS, 134(6). https://doi.org/10.1111/apm.70226

Vancouver

Riishede A, Merrild C, Hyun S, Madsen MG, Keller AK, Mutsaers HAM, et al. Histopathological Assessment of Precision‐Cut Kidney Slices: A Live Human Tissue‐Based Model of Renal Fibrosis. APMIS. 2026;134(6). doi:10.1111/apm.70226

BibTeX
@article{Riishede2026,
  author = {Riishede, Andreas and Merrild, Camilla and Hyun, Seulgi and Madsen, Mia G and Keller, Anna K and Mutsaers, Henricus A M and Nørregaard, Rikke and Nejsum, Lene N},
  title = {Histopathological Assessment of Precision‐Cut Kidney Slices: A Live Human Tissue‐Based Model of Renal Fibrosis},
  journal = {APMIS},
  year = {2026},
  volume = {134},
  number = {6},
  doi = {10.1111/apm.70226}
}
Kostenlos starten →